Intellectual Property

  • December 16, 2025

    NCAA Escapes Former Villanova Star's Antitrust Suit

    A Villanova University basketball player who sank a buzzer-beating shot to win the 2016 championship missed the window to bring an antitrust lawsuit accusing the NCAA of unlawfully limiting his ability to earn money, a New York federal judge has ruled.

  • December 16, 2025

    USPTO Tells Fed. Circ. That Inventor 'Abused' Patent System

    The U.S. Patent and Trademark Office is urging the Federal Circuit to ignore an inventor's call to end doctrine that can render a patent unenforceable based on delays by the owner during prosecution, saying his actions were "a textbook example of unreasonable examination delays."

  • December 16, 2025

    Disney, Cameron Face Copyright Suit Over 1st 'Avatar' Sequel

    Film director James Cameron, his production company and Disney were hit with another copyright infringement lawsuit on Monday from the writer who previously alleged the first "Avatar" movie ripped off his idea, who says in California federal court that the second one is a "blatant" ripoff of his work.

  • December 16, 2025

    DOD Contractor Says Engineer Stole 2K Files On Last Day

    Defense contractor Competitive Range Solutions LLC is suing a field engineer in Virginia federal court, accusing him of violating the Defend Trade Secrets Act by downloading thousands of confidential documents at the end of his last day of work and after accepting a job with a competitor.

  • December 16, 2025

    PTAB Cuts X-Ray Patent Claims After Fed. Circ. Remand

    The Patent Trial and Appeal Board has found that three claims that Sigray Inc. challenged in a Carl Zeiss X-Ray Microscopy Inc. X-ray imaging patent were invalid after the Federal Circuit told it to take another look at the claims.

  • December 16, 2025

    Va. Judge Advances Most Claims In Stelara Antitrust Case

    A Virginia federal judge has allowed health insurer CareFirst's anticompetition and patent fraud claims against Johnson & Johnson to move forward in a case alleging anticompetitive behavior in relation to the immunosuppressive drug Stelara, while letting the pharmaceutical giant escape some claims of misrepresentation.

  • December 16, 2025

    Judge Trims Ziff Davis Copyright Claims In OpenAI MDL

    A Manhattan federal judge has dismissed part of a suit from digital media publisher Ziff Davis Inc. against OpenAI alleging that its chatbot ChatGPT was trained on copyrighted content scraped from the internet and gives re-creations of those works when prompted.

  • December 16, 2025

    NC Cardboard Box Salesman Freed From Trade Secrets Suit

    A corrugated packing manufacturer can't hold on to its lawsuit alleging a former star salesman defected to a close competitor with its trade secrets after a North Carolina Business Court judge ruled the complaint is too vague.

  • December 16, 2025

    Fed. Circ. Stunned By 'Numerous' Flaws In Patent Appeal

    The Federal Circuit refused Tuesday to revive a patent licensing company's infringement lawsuit over a software patent, finding there were so many issues with the appeal that they "are almost too numerous to count."

  • December 16, 2025

    Jury Says Magnolia Medical Is Owed $1.6M After Patent Trial

    A Delaware federal jury on Tuesday morning found that Magnolia Medical Technologies Inc. is entitled to nearly $1.6 million after Kurin Inc. infringed its patents tied to devices meant for drawing blood.

  • December 16, 2025

    Another Dechert IP Atty Leaves, This Time For Morgan Lewis

    Morgan Lewis LLP has added another departing member of the Dechert LLP intellectual property team, who joins the firm in Boston after Dechert's global intellectual property practice co-chair, two partners, and a total of 30 professionals moved to Cooley LLP last week.

  • December 15, 2025

    2nd Circ. Won't Revive Ex-Basketball Players' NIL Claims

    The Second Circuit on Monday refused to revive a putative class action filed by former college basketball players claiming the NCAA unjustly profited from use of their names and images years after their careers ended, saying the "continuing violation doctrine" doesn't apply and the suit was filed too late.

  • December 15, 2025

    Smartwatch Giants Sued Over Fall Detection Patents

    A company that makes medical alert watches for the elderly has sued Apple, Samsung, Google and Garmin in federal court and the U.S. International Trade Commission, alleging that the fall detection features in their smartwatches infringe two patents.

  • December 15, 2025

    Starbucks' 'Patent Troll' Suit Is Unwarranted, Irish Cos. Say

    Two Irish companies that hold and license technology patents on Monday asked a federal court in Seattle to throw out Starbucks' lawsuit accusing them of bringing bad-faith intellectual property claims in violation of Washington state law, arguing that they never actually threatened to bring litigation against the coffee giant.

  • December 15, 2025

    USPTO Says 'Settled Expectations' Denials Sink Google Case

    The U.S. Patent and Trademark Office has told the Federal Circuit that the court's recent rejection of other petitions challenging the office's policy of denying patent reviews based on the owner's "settled expectations" means a case by Google on the same issue must also fail.

  • December 15, 2025

    USPTO Replaces Denver Office With Center In Montana

    Montana has been picked by the U.S. Patent and Trademark Office to be the first state to oversee community outreach in the area formerly serviced by the now-shuttered Rocky Mountain Regional Outreach Office in Denver.

  • December 15, 2025

    E-Cig Makers Want Court To Block ITC Patent Probe

    The proper avenue for patent owners to hold would-be infringers accountable is in the federal courts, not before the U.S. International Trade Commission, Altria Group and its NJOY vaping subsidiary said in a bid to stop an infringement action against them at the ITC.

  • December 15, 2025

    Lady Gaga Can Keep Using 'Mayhem' Mark For Now, Judge Says

    A California federal judge on Monday refused to grant a surfing brand a preliminary injunction against Lady Gaga from using the "Mayhem" mark on the clothing she sells, saying the brand had not shown that it was likely to succeed on its trademark infringement claims.

  • December 15, 2025

    Fed. Circ. Won't Revive Bard Patents In AngioDynamics Row

    The Federal Circuit on Monday refused to revive claims in C.R. Bard patents on implanted catheter receptacles that were challenged by AngioDynamics, backing a Delaware federal court's finding that the claims were anticipated.

  • December 15, 2025

    Fed. Circ. Backs Denial Of 'Basin' Beverage Mark

    The Federal Circuit held Monday that a man's attempt to secure a trademark for his company "Basin Beverage Co." should be denied due to the likelihood of causing confusion with at least three registered marks with "Basin" in their name.

  • December 15, 2025

    Texas, Toronto Stock Exchanges End Trademark Dispute

    The Texas Stock Exchange has buried the hatchet with the Toronto Stock Exchange and ended its suit seeking a court finding that the two exchanges' logos are dissimilar. 

  • December 15, 2025

    The Top Patent Decisions Of 2025

    The Federal Circuit decided its first en banc utility patent case in years and expanded who can use the U.S. International Trade Commission, while both the appeals court and U.S. Patent and Trademark Office took on the eligibility of AI patents. Here's a look at the top patent decisions of 2025.

  • December 15, 2025

    PTAB Creates New Prehearing Conference For AIA Reviews

    The Patent Trial and Appeal Board has rolled out a change to its trial practice guide that will create a new prehearing conference 15 days prior to oral hearings under the America Invents Act in cases implemented by the U.S. Patent and Trademark Office director.

  • December 15, 2025

    Supreme Court Turns Down Entresto Patent Fight

    The U.S. Supreme Court on Monday rejected a petition from MSN Pharmaceuticals Inc. claiming the Federal Circuit improperly applied what is known as after-arising technology when reviving a patent covering Novartis Pharmaceuticals Corp.'s blockbuster cardiovascular drug Entresto.

  • December 15, 2025

    Inventor's Bid To Dodge $214K Sanction Fails At High Court

    The U.S. Supreme Court on Monday declined to take on an inventor's request to escape an order from an Ohio federal court that sanctioned him $214,000 for bad faith litigation, which was approved by the Federal Circuit.

Expert Analysis

  • Patent Claim Lessons From Fed. Circ.'s Teva Decision

    Author Photo

    The Federal Circuit's recent decision in Janssen v. Teva is an important precedent for parties drafting patent claims or litigating obviousness where the prior art has potentially overlapping ranges for a claimed element, and may be particularly instructive to patent applicants in the pharmaceutical field, say attorneys at Cooley.

  • Series

    Law School's Missed Lessons: Adapting To The Age Of AI

    Author Photo

    Though law school may not have specifically taught us how to use generative artificial intelligence to help with our daily legal tasks, it did provide us the mental building blocks necessary for adapting to this new technology — and the judgment to discern what shouldn’t be automated, says Pamela Dorian at Cozen O'Connor.

  • Ch. 11 Ruling Voiding $2M Litigation Funding Sends A Warning

    Author Photo

    A recent Texas bankruptcy court decision that a postconfirmation litigation trust has no obligations to repay a completely drawn down $2 million litigation funding agreement serves as a warning for estate administrators and funders to properly disclose the intended financing, say attorneys at Kleinberg Kaplan.

  • Future-Proof Patent Law By Starting Talent Pipelines Early

    Author Photo

    Law firms struggling with a narrow talent pipeline in the intellectual property space should consider beginning their recruitment strategies for potential candidates as early as high school, and raise awareness for career opportunities that do not require a law degree, says Christine Hollis at Marshall Gerstein.

  • Demystifying The Civil Procedure Rules Amendment Process

    Author Photo

    Every year, an advisory committee receives dozens of proposals to amend the Federal Rules of Civil Procedure, most of which are never adopted — but a few pointers can help maximize the likelihood that an amendment will be adopted, says Josh Gardner at DLA Piper.

  • How USPTO Examiner Memo Informs Software Patent Drafting

    Author Photo

    A memorandum recently released by the U.S. Patent and Trademark Office provides useful clues as to how the USPTO and examining corps will evaluate claims in software-implemented inventions for subject matter eligibility going forward, says Michael Lew at Squire Patton.

  • FTC, CoStar Cases Against Zillow May Have Broad Impact

    Author Photo

    Zillow's partnerships with Redfin and Realtor.com have recently triggered dual fronts of legal scrutiny — an antitrust inquiry from the Federal Trade Commission and a mass copyright infringement suit from CoStar — raising complex questions that reach beyond real estate, says Shubha Ghosh at Syracuse University College of Law.

  • Parenting Skills That Can Help Lawyers Thrive Professionally

    Author Photo

    As kids head back to school, the time is ripe for lawyers who are parents to consider how they can incorporate their parenting skills to build a deep, meaningful and sustainable legal practice, say attorneys at Alston & Bird.

  • Enablement Standard Insights From Fed. Circ. Agilent Ruling

    Author Photo

    The Federal Circuit's recent enablement standard decision in Agilent v. Synthego underscores three critical takeaways for patent practitioners, including reaffirmation that the enablement inquiry under Section 102 of the Patent Act is distinct from the inquiry under Section 112, say attorneys at MoFo.

  • How WTO's Anti-Suit Injunction Ruling Affects IP Stakeholders

    Author Photo

    The World Trade Organization's recent ruling in favor of the European Union's challenge to Chinese courts' anti-suit injunction practices should hearten holders of standard-essential patents, while implementers can take solace that they retain mechanisms to distinguish the WTO decision when seeking anti-suit injunctions in U.S. courts, says Michael Franzinger at Dentons.

  • Series

    Teaching Trial Advocacy Makes Us Better Lawyers

    Author Photo

    Teaching trial advocacy skills to other lawyers makes us better litigators because it makes us question our default methods, connect to young attorneys with new perspectives and focus on the needs of the real people at the heart of every trial, say Reuben Guttman, Veronica Finkelstein and Joleen Youngers.

  • Why Civil RICO Claims Are Gaining Traction With Plaintiffs

    Author Photo

    A Texas federal court's recent $71 million verdict in Point Bridge Capital v. Johnson demonstrates that, when used properly, civil lawsuits under the Racketeering Influenced and Corrupt Organizations Act can be a devastating weapon — and increasingly favorable for plaintiffs, says Akiva Shapiro at Gibson Dunn.

  • You're Out?: Rooftop Views Of Sports Games Raise IP Issues

    Author Photo

    A high-profile dispute between the Chicago Cubs and a rooftop business adjacent to Wrigley Field strikes at the intersection of sports, intellectual property and Chicago neighborhood tradition, highlighting novel questions that could significantly affect IP rights in the context of live events generally, say attorneys at Troutman Pepper.

  • 5 Key Steps To Prepare For Oral Arguments

    Author Photo

    Whether presenting oral arguments before the U.S. Supreme Court or a local county judge, effective preparation includes the same essential ingredients, from organizing arguments in blocks to maximizing the potential of mock exercises, says Allison Rocker at Baker McKenzie.

  • A Change In Big Pharma Response To FTC Delisting Warnings

    Author Photo

    While the effect of Federal Trade Commission notices to pharmaceutical companies about allegedly improper patent listings in the U.S. Food and Drug Administration's Orange Book had been de minimis through the end of last year, July data shows an increase in delistings, say Ratib Ali and Celia Lu at Competition Dynamics.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.